POSTER: AML-596 Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Mutated Isocitrate Dehydrogenase 1-Relapsed/Refractory Acute Myeloid Leukemia

Justin Watts; Brian A. Jonas; Eunice S. Wang; Florence R. Wilson; Julie Park; Shannon Cope; Aaron D. Sheppard; Stéphane de Botton; Jorge Cortes

doi:10.1016/S2152-2650(25)00548-8

$POSTER: AML-596 Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Mutated Isocitrate Dehydrogenase 1-Relapsed/Refractory Acute Myeloid Leukemia$

Journal article

Peer reviewed

POSTER: AML-596 Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Mutated Isocitrate Dehydrogenase 1-Relapsed/Refractory Acute Myeloid Leukemia

Justin Watts, Brian A. Jonas, Eunice S. Wang, Florence R. Wilson, Julie Park, Shannon Cope, Aaron D. Sheppard, Stéphane de Botton and Jorge Cortes

Clinical lymphoma, myeloma and leukemia, Vol.25, pp.S190-S190

2025-09

DOI: https://doi.org/10.1016/S2152-2650(25)00548-8

Appears in Miller School of Medicine - Latest Publications

Metrics

1 Record Views

Details

Title: POSTER: AML-596 Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Mutated Isocitrate Dehydrogenase 1-Relapsed/Refractory Acute Myeloid Leukemia
Creators: Justin Watts - University of Miami
Brian A. Jonas - University of California, Davis
Eunice S. Wang - Roswell Park Comprehensive Cancer Center
Florence R. Wilson - Precision AQ, Vancouver, BC, Canada
Julie Park - Precision AQ, Vancouver, BC, Canada
Shannon Cope - Precision AQ, Vancouver, BC, Canada
Aaron D. Sheppard - Rigel
Stéphane de Botton - Laboratoire d'hématologie
Jorge Cortes - Augusta University
Publication Details: Clinical lymphoma, myeloma and leukemia, Vol.25, pp.S190-S190
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032797025102976